BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
nitric oxide metabolic process
,
Pseudomonas infection
,
Kidney
,
Prozac
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
2- deoxy- d- glucose
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Human cancer cells treated with unfolded protein response modulators under stress conditions
Determinants of FDG-retention in cancer cell lines and primary human tumors
Explore Curated Studies Results
Literature
Most Relevant Literature
D-Glucose and D-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated D-gluco…
Regulation of the proliferation of colon cancer cells by compounds that affect glycolysis, including…
In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog.
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients wi…
Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epi…
Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors
Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mam…
18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ